Biechele, Gloria
Rauchmann, Boris-Stephan
Janowitz, Daniel
Buerger, Katharina
Franzmeier, Nicolai
Weidinger, Endy
Guersel, Selim
Schuster, Sebastian
Finze, Anika
Harris, Stefanie
Lindner, Simon
Albert, Nathalie L.
Wetzel, Christian
Rupprecht, Rainer
Rominger, Axel
Palleis, Carla
Katzdobler, Sabrina
Burow, Lena
Kurz, Carolin
Zaganjori, Mirlind
Trappmann, Lena-Katharina
Goldhardt, Oliver
Grimmer, Timo
Haeckert, Jan
Keeser, Daniel
Stoecklein, Sophia
Morenas-Rodriguez, Estrella
Bartenstein, Peter
Levin, Johannes
Höglinger, Günter U.
Simons, Mikael
Perneczky, Robert
Brendel, Matthias
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy – ID 390857198)
Universitätsklinik München
Article History
Received: 25 October 2023
Accepted: 11 January 2024
First Online: 23 January 2024
Declarations
:
: Patients and age-matched healthy controls were included after providing written informed consent in line with the declaration of Helsinki. The study was approved by the ethics committee of LMU Munich (project numbers 17-755 and 17-569).
: Not applicable.
: TG received consulting fees from AbbVie, Alector, Anavex, Biogen, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Noselab, Novo Nordisk, NuiCare, Orphazyme, Roche Diagnostics, Roche Pharma, UCB, and Vivoryon; lecture fees from Grifols, Medical Tribune, Novo Nordisk, Roche Pharma, and Schwabe; and has received grants to his institution from Roche Diagnostics. GUH participated in industry-sponsored research projects from Abbvie, Biogen, Biohaven, Novartis, Roche, Sanofi, UCB; serves as a consultant for Abbvie, Alzprotect, Aprineua, Asceneuron, Bial, Biogen, Biohaven, Kyowa Kirin, Lundbeck, Novartis, Retrotope, Roche, Sanofi, UCB; received honoraria for scientific presentations from Abbvie, Bayer Vital, Bial, Biogen, Bristol Myers Squibb, Kyowa Kirin, Roche, Teva, UCB, Zambon; holds a patent on Treatment of Synucleinopathies. United States Patent No.: US 10,918,628 B2: EP 17 787 904.6-1109 / 3 525 788; received publication royalties from Academic Press, Kohlhammer, and Thieme. RP has received honoraria for advisory boards and speaker engagements from Roche, EISAI, Eli Lilly, Biogen, Janssen-Cilag, Astra Zeneca, Schwabe, Grifols, Novo Nordisk and Tabuk. MB received speaker honoraria from GE healthcare, Roche and LMI and is an advisor of LMI.